Note: Ingredients listed on restricted chemical lists
EC/CAS
60-32-2
Name of the chemical
Aminocaproic acid (INN) and its salts
Concentration
N/A
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
N/A
EC/CAS
94-13-3
Name of the chemical
Propylparaben; propyl 4-hydroxybenzoate
Concentration
N/A
EC/CAS
50-70-4
Name of the chemical
D-glucitol C6H14O6
Concentration
N/A
EC/CAS
99-76-3
Name of the chemical
4-hydroxybenzoic acid, methyl ester
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
EC/CAS
128-44-9
Name of the chemical
1,2-benzisothiazol-3(2H)-one 1,1-dioxide, sodium salt
Concentration
N/A
General Information
Revision date
2020-01-14
Product name
Aminocaproic Acid Oral Solution USP
Chemical name
Aminocaproic Acid Oral Solution USP
1.2.1 Relevant identified uses
Rx Pharmaceutical for human use
Emergency telephone
(727) 530-1633
Icons in SDS
Company Information
company name
VistaPharm, Inc
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
This product is a mixture that has not been fully tested as a whole. Information provided herein is derived from the approved product insert and/or supplier SDS for hazardous ingredients. See section XI,
TOXICOLOGICAL INFORMATION
for additional data Toxic; Irritant (e.g., skin, eye, respiratory)
Signal word
WARNING Inhalation: Harmful if inhaled. May cause irritation to respiratory tract. Ingestion: Harmful if ingested. Skin Contact: May be harmful by skin absorption. May cause irritation. Eye Contact: May cause irritation.
Physical hazards
None known. Chronic Exposure: Hypersensitivity; cardiac and hepatic lesions; myopathy, myalgia and necrosis of muscle fibers. Conditions Hypotension; acute renal failure; clotting or thrombosis in the renal pelvis and Aggravated by ureters; active intravascular clotting. Exposure: Systemic Effects: Fibrinolysis-inhibitory effects. Repeated, excessive ingestion may cause CNS and laxative effects.
